Dentium

145720 · KOSPI · Health Care · SMALL CAP

Net income turned to a loss.

Dentium filed provisional (unaudited) consolidated results for Q4 2025: revenue of US$75.2M (−8.1% year on year), operating profit of US$18.3M (−2.5% year on year) and a net loss of US$3.2M (from a profit a year earlier).

Earnings(Operating results (consolidated) (preliminary) (fair disclosure))· FILED 2026-03-03· RCEPT 20260303800672

US$75.2MRevenue
−8.1%Revenue vs a year earlier
US$18.3MOperating profit

Converted at 1 USD ≈ ₩1,452.27 (filing-date rate, 2026-03-03 close)

What happened

Dentium filed provisional (unaudited) consolidated results for Q4 2025: revenue of US$75.2M (−8.1% year on year), operating profit of US$18.3M (−2.5% year on year) and a net loss of US$3.2M (from a profit a year earlier).

These are preliminary figures the company disclosed ahead of its audited report; the final numbers can differ.

RevenueUS$75.2M
Revenue vs a year earlier−8.1%
Operating profitUS$18.3M
Net income−US$3.2M
PeriodQ4 2025 (consolidated)
Filed2026-03-03, Operating results (consolidated) (preliminary) (fair disclosure)
SourceDART rcept 20260303800672 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-03-03 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.